RCOR
Renovacor Inc

23
Loading...
Loading...
Renovacor, Inc. operates as a clinical stage gene therapy company. It researches and develops AAV-based gene therapies for BAG3 gene mutation-associated diseases. Its therapeutic focus is on cardiovascular diseases. The company was founded by Arthur Michael Feldman on June 7, 2013 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Renovacor Inc?
What is the 52-week high for Renovacor Inc?
What is the 52-week low for Renovacor Inc?
What is Renovacor Inc stock price today?
What was Renovacor Inc stock price yesterday?
What is the PE ratio of Renovacor Inc?
What is the Price-to-Book ratio of Renovacor Inc?
What is the 50-day moving average of Renovacor Inc?

Latest RCOR News

View
No RCOR news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.